ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials.
Using our proprietary ModiVacc™ (hyper-immune stimulatory cell immunization), ModiFuse™ (electrofusion-based hybridoma generation), ModiSelect™ (antigen-specific B-cell selection) and ModiPhage™ (phage display) technologies, we can generate monoclonal antibodies from multiple species against virtually any target. Besides lead antibody generation, we also provide antibody engineering such as affinity maturation and humanization (ModiTune™), and production in transient and stable mammalian cell systems (ModiXpress™). All services are offered on a fee-for-service basis.
Area of work
Drug discovery, Drug development, Oncology, Immunology, Antibodies, Inflammatory diseases, Diagnostics
Services and products
Besides generating monoclonal antibodies, ImmunoPrecise Antibodies offers a range of immunological products to enable early research into new antibody therapeutics and diagnostics. These products contain unique and highly specialised reagents to enable research in autoimmune disease, infectious diseases including fungal and parasitic diseases and oncology.
To learn more about our product portfolio with all further details and specifications please click on this link: productportfolio (note: link will redirect to Modiquest Research website).
When interested in our services or products, please contact us via:
- email: firstname.lastname@example.org
- phone: +31 (0)412 846000
Our clients span academic institutes, small biotech, right through large pharma companies.
You can always apply for internship with Ilse Roodink – email@example.com